MTOR and neoplasm: The concurrent inhibition of GLI and PI3K/AKT/mTOR signaling demonstrated a synergistic effect in inhibiting in vivo cancer cell growth, evident by reduced tumor burden of xenografts compared to treatment with any of the agents alone [105].